Nasdaq:US$17.54 (-0.39) | HKEX:HK$26.82 (-0.86) | AIM:£2.51 (+0.01)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 其他業務 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture